Effect of polyethylene glycol versus lactulose on abdominal pain in children occult constipation: a randomized

Mehran Hakimzadeh1, Sayeh Mottaghi1, Mitra Ahmadi1

  • 1Dept. of Pediatric Gastroenterology, Abuzar Children's Hospital, Ahvaz Jundishapur University of Medical Sciences. Ahvaz, Iran.

Insights

Polyethylene glycol (PEG) is more effective than lactulose for treating functional abdominal pain caused by occult constipation in children. PEG showed a 48% efficacy rate, compared to 37% for lactulose.

Area of Science:

  • Pediatric Gastroenterology
  • Clinical Pharmacology

Background:

  • Functional abdominal pain (FAP) is a common pediatric gastrointestinal issue.
  • Occult constipation (OC) is a frequent cause of FAP in children.
  • Laxatives are increasingly explored for treating FAP associated with OC.

Purpose of the Study:

  • To compare the efficacy of polyethylene glycol (PEG) and lactulose in treating children with occult constipation.
  • To investigate factors influencing treatment outcomes for FAP in pediatric OC.

Main Methods:

  • A study involving 51 pediatric patients (4-18 years) diagnosed with OC via X-ray.
  • Patients received either PEG (1g/kg) or lactulose (1cc/kg) for at least two weeks.
  • Pain reduction was assessed using a pain measurement scale post-treatment.

Main Results:

  • Polyethylene glycol (PEG) demonstrated a higher efficacy (48%) in reducing abdominal pain compared to lactulose (37%).
  • Treatment efficacy was not significantly influenced by patient sex or fecal odor.
  • Age, body weight, duration, and severity of abdominal pain impacted the effectiveness of both PEG and lactulose.

Conclusions:

  • Polyethylene glycol (PEG) is a more effective therapeutic option for pediatric functional abdominal pain associated with occult constipation than lactulose.
  • Optimal outcomes with PEG appear to be associated with older age and more severe abdominal pain.
Abstract

Related Concept Videos

Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
614
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
544
Drugs Affecting GI Tract Motility: Other Laxatives01:20

Drugs Affecting GI Tract Motility: Other Laxatives

Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
923
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives01:22

Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives

Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
475
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents01:17

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
556
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents01:20

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
513